Creative regulatory practices to develop stem-cell technology: the way forward for Malaysia

Document Type

Article

Publication Date

2-1-2022

Abstract

Malaysia aspires to develop regenerative medicine through stem-cell technology. It needs a regulatory system that could facilitate development and prevent unethical practices. A comparative legal analysis on the regulation of stem-cell technology, with a focus on stem-cell research in Malaysia and selected Commonwealth countries that are experienced in regulating this complex technology, demonstrates that the selected Commonwealth countries have adopted a hybrid of different regulatory mechanisms. This paper argues that Malaysia should consider adopting a similar approach to equip relevant authorities with different regulatory mechanisms that are able to promote innovation in stem-cell research activities and cultivate a successful and profitable regenerative medicine industry in the future. Such a strategic action can produce an optimal regulatory outcome and help Malaysia to realize its aspiration.

Keywords

Commonwealth, Ethics, Innovation, Malaysia, Regenerative medicine, Regulation, Stem cells

Publication Title

Regenerative Medicine

Divisions

fac_law

Volume

17

Issue

2

Publisher

Future Medicine Ltd

Publisher Location

UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND

This document is currently not available here.

Share

COinS